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Novel Aspect 
This unique method enables rapid analysis of several different groups of sweeteners in human urine in one 
run. It may serve to identify biomarkers in nutritional research. 
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Introduction 
Low-dose acetylsalicylic acid (ASA, 100 mg/die) is used in thromboprophylaxis. Enteric-coated formulation 
(EC-ASA) is commonly used for its lower risk of side effects. Some patients on EC-ASA do not respond 
appropriately and recent studies showed that poor responsiveness is more frequent with EC-ASA [1]. Aim 
of this study was to validate a method useful to study the pharmacokinetics (PK) of ASA in healthy subjects 
treated with two different aspirin formulations. 
 
Methods 
Liquid chromatography tandem mass spectrometry (LC-MS/MS) technique was used for determination of 
ASA and salicylic acid (SA) in human plasma, using the respective deuterated isotopomers as internal 
standards (ASA-d4, SA-d4). The method was validated according to FDA guidelines and was applied to 
evaluate the PK of ASA and SA at different times (30 min-24 h) in healthy subjects (n=11) treated for 1 week 
with 100 mg of EC-ASA or plain Aspirin (plain-ASA). 
 
Results 
Analytes and internal standards were extracted from human plasma by protein. The compounds were 
separated on a reverse-phase column with an isocratic mobile phase. Compounds parameter were 
optimized to have the higher signal to noise ratio in negative multiple reaction mode. Ion transition 
recorded were 179→137 for ASA, 183→141 for ASA-d4, 137→93 for SA and 137→141 for SA-d4. The 
calibration curves were linear (r2≥0.99) over the concentration range of 20-2000 ng/mL for ASA and 20-
8000 ng/mL for SA. LOQ was 20 ng/mL for both. 
Plasma AU Cafter EC-ASA administration was 702(604-881) ng h/mL (median, 25%-75% CI). tmax occurred 
between 2-8 hours after intake. Two subjects did not show ASA absorption within the observation period 
confirmed by SA trend. PK of plain-ASA showed AUC of 823 (635-1013) ng h/mL and all subjects absorbed 
the drug with tmax between 0.5-1 h. 
 
Conclusions 
The developed method allowed to study the analytical fate of aspirin “in vivo” by comparing two different 
 393 
ASA formulations. Coated formulation showed a variable behavior and in 2 subjects absorption seemed 
impaired. On the contrary using plain-ASA variation is reduced and all subjects absorbed efficiently the 
drug. Causes of inadequate response to ASA may be related to different gastro-intestinal availability of 
coated formulation. 
 
Novel Aspect 
Availability of a validated method is pivotal to study ASA absorption and metabolism in different cohorts of 
patients known to have poor pharmacodynamics responses to the drug. 
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Introduction 
Steroid hormones control many physiological aspects in our body. A robust, sensitive, accurate and specific 
LC/MS/MS analytical method has been developed for the quantitation of 19 steroids in serum. A simple 
liquid-liquid extraction sample preparation allows achieving the required sensitivity. This research study 
was carried out to evaluate which LC-MS/MS instrument is best suited to characterize and quantitate the 
steroids in serum. 
 
Methods 
Thermo Scientific™ TSQ Fortis™, Thermo Scientific™ TSQ Quantis™, and Thermo Scientific™ TSQ Altis™ 
tandem mass spectrometers and a Thermo Scientific™ Vanquish™ HPLC system were utilized. A 200 µL 
serum sample was used and a Thermo Scientific™ Accucore™ C18 column achieved baseline 
chromatographic separation. Quantitative analysis was performed using SRM scan in positive and negative 
mode. Accuracy of the analytical method was verified using reference samples. 
 
Results 
Good linearity and reproducibility were obtained with the concentration range from 10 pg/ml to 1000 
ng/ml for the steroids with a coefficient of determination >0.995 for all mass spectrometer platforms. The 
lower limit of detection (LLOD) and lower limit of quantitation (LLOQ) were determined. Excellent 
reproducibility was observed for all platforms, being the %CV for each calibration point always < 10% for all 
steroids. The inter-assay precision was determined by extracting and quantifying three replicates of in-
house control material resulting in %CV for the steroids of < 10% deviation from the targeted mean. The 
inter-assay precision was determined over three consecutive days and was found to have a %CV < 10% for 
each steroid within its respective linear range for the three levels of pooled serum sample control material 
respectively. The accuracy was determined by the analysis of in-house control material as the percentage 
deviation from the targeted mean. The results were < 10% for all levels in each matrix. 
 
Conclusions 
A sensitive, simple, specific and accurate liquid chromatography QQQ mass spectrometry analytical method 
was developed and verified for the measurement of 19 steroids in serum and applied to any Thermo 
Scientific™ tandem mass spectrometer platform. The sample preparation technique is quick and easily 
